 您的位置：对照品 > 标准品 > 农药标准品 > |
|
|
|
| 产品基本信息 |
|
| 产品编号：D206090 |
| 产品名称：N-De-boc 6-Hydroxy-7-epi Docetaxel 12-Acetate |
| 产品CAS： |
| 规格含量：1mg |
| 产品价格：面议 |
| 联系我们: |
 |
|
 |
|
|
| 产品详细介绍 |
| 标准品编号: |
D206090 |
| 名称: |
N-De-boc 6-Hydroxy-7-epi Docetaxel 12-Acetate |
| 别名: |
(3S,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-Amino-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-3,4,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H,7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl Diacetate; |
| 分子式: |
C₄₀H₄₇NO₁₄ |
| 分子量: |
765.8 |
| 种类: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: |
N-De-boc 6-Hydroxy-7-epi Docetaxel 12-Acetate is an intermediate used in the synthesis of 6-Oxo-7-epi Docetaxel (Technical Grade) (O870058), which is a Docetaxel impurity. Taxol derivatives are useful for the same cancers for which Taxol (Paclitaxel-P132500) has been shown active, including human ovarian cancer, breast cancer, and malignant melanoma as well as lung cancer, gastric cancer, colon cancer, head and neck cancer, and leukemia. |
| 参考文献 |
|
|
|
|
|
|
